Quest Diagnostics

Quest Diagnostics ROA

The Return on Assets (ROA) of Quest Diagnostics (DGX) as of Nov 20, 2026 is 6.11 %. In the previous year, Return on Assets (ROA) was 5.39 % — a change of 13.39% (higher).

ROA

6.11 %

YoY

13.39%

Last updated:

In 2025, Quest Diagnostics's return on assets (ROA) was 6.11 %, a 13.39% increase from the 5.39 % ROA in the previous year.

The Quest Diagnostics ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
6.69 USD
Jan 1, 2019
6.68 USD
Jan 1, 2020
10.20 USD
Jan 1, 2021
14.66 USD
Jan 1, 2022
7.37 USD
Jan 1, 2023
6.09 USD
Jan 1, 2024
5.39 USD
Jan 1, 2025
6.11 USD
The Quest Diagnostics ROA history
YEARROAYoY
6.11 %+13.39%
5.39 %-11.46%
6.09 %-17.35%
7.37 %-49.72%
14.66 %+43.66%
10.20 %+52.72%
6.68 %-0.13%
6.69 %-9.00%
7.35 %+15.10%
6.39 %-10.27%
7.12 %+26.43%
5.63 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quest Diagnostics Stock analysis

What does Quest Diagnostics do? Quest Diagnostics Inc is a leading company in the field of diagnostic information and services, headquartered in New Jersey, USA. The company is dedicated to providing medical professionals and patients worldwide with fast, accurate, and preventive diagnostic tests. The history of Quest Diagnostics dates back to 1967 when the company MetPath was founded by Dr. Paul A. Brown. In the following years, several acquisitions and mergers took place, eventually leading to the establishment of Quest Diagnostics in 1996. Since then, the company has continuously evolved and now offers a wide range of diagnostic tests and services, ranging from the analysis of blood samples to genetic testing procedures. The business model of Quest Diagnostics is based on providing high-quality and individualized information to medical professionals and patients to assist in the diagnosis, treatment, and cure of their health problems. The company works closely with doctors, hospitals, and other medical institutions worldwide to offer a comprehensive range of innovative diagnostic products, procedures, and technologies tailored to meet specific needs. Quest Diagnostics offers a wide range of services, ranging from laboratory testing to data management and clinical trials. The company has various business segments, including the Diagnostic Services business, the Medical Research Services business, and the Information Services business. In the field of Diagnostic Services, Quest Diagnostics offers a broad spectrum of laboratory tests divided into different categories such as cancer diagnostics, cardiology, endocrinology, immunology, and infectious diseases. The company also provides a variety of genetic tests that enable precise analysis of individual genomes, supporting the diagnosis and treatment of various genetic disorders. In the medical research field, Quest Diagnostics provides a range of services to support clinical trials and drug development. The company also offers a wide range of laboratory tests used in biomedical research to improve people's health and well-being. The Information Services business segment of Quest Diagnostics mainly focuses on providing innovative solutions in the field of data management and information technology. This includes the development of software tools that can be used for the analysis and management of health data. Additionally, the company offers consulting services to help medical professionals address challenges related to information processing and data integration. Quest Diagnostics is a company based on innovation and knowledge that collaborates closely with doctors, clinics, and other medical facilities worldwide to offer a relatively comprehensive range of need-specific diagnostic products, procedures, and solutions. From cancer diagnostics to genomic diagnostics, from clinical trials to information and data services, and a wide range of molecular diagnostic tests and laboratory analyses, Quest Diagnostics provides top-notch solutions for optimal patient care, contributing to the goal of improving global healthcare for people worldwide. Quest Diagnostics is one of the most popular companies on Eulerpool.

ROA Details

Understanding Quest Diagnostics's Return on Assets (ROA)

Quest Diagnostics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Quest Diagnostics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Quest Diagnostics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Quest Diagnostics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Quest Diagnostics stock

Return on Assets (ROA) of Quest Diagnostics is 6.11 % in 2025.

Return on Assets (ROA) of Quest Diagnostics changed from 5.39 % to 6.11 %, representing a 13.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Quest Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Quest Diagnostics with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Quest Diagnostics

All Key Metrics — Quest Diagnostics